Development of an HPV 16 mRNA Based Therapeutic Vaccine Overcoming High Grade HPV Infections
Time: 4:15 pm
day: Conference Day One
Details:
- Preclinical data indicating efficacy of the vaccine in inducing immune response and reducing tumor growth
- Future directions and potential applications for mRNA-based therapeutic vaccines in HPV treatment and beyond
